Streetbeat News

Analyst Ratings

SAGE

Morgan Stanley analyst Vikram Purohit maintains an Equal-Weight rating on Sage Therapeutics (NASDAQ:SAGE) and keeps the price target at $49.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:47 pm

VZ

Morgan Stanley analyst Simon Flannery has reiterated an Overweight rating on Verizon Communications (NYSE:VZ) and maintained a $44 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:47 pm

Z

ZG

Zillow Group Inc (NASDAQ:ZG) (NASDAQ:Z) reported Q2 earnings that beat consensus estimates, with earnings of 39 cents per share and revenues of $506 million. However, the company's Q3 revenue forecast is below consensus estimates. Analysts from Needham, Cannacord, KeyBanc, and JMP have maintained their ratings on the stock, citing strong Q2 results but also potential challenges due to macro conditions and near-term investments.

Portfolio Pulse from AJ Fabino

August 04, 2023 | 1:46 pm

PACB

Morgan Stanley analyst Tejas Savant has maintained an Equal-Weight rating on Pacific Biosciences (NASDAQ:PACB) and raised the price target from $12 to $13.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:46 pm

IBP

Truist Securities analyst Keith Hughes maintains a 'Buy' rating on Installed Building Products (NYSE:IBP) and raises the price target from $140 to $170.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:46 pm

AAPL

QCOM

Shares of Qualcomm Inc (NASDAQ:QCOM) plunged after the company announced weak guidance. Analysts from Susquehanna, KeyBanc Capital Markets, Canaccord Genuity Capital Markets, Oppenheimer, and Raymond James provided their insights on the company's performance and outlook. The analysts highlighted issues such as soft handset demand, macro headwinds, and channel inventory drain. However, they also noted Qualcomm's potential to diversify into other areas such as RF, Auto, IoT, and beyond.

Portfolio Pulse from Priya Nigam

August 04, 2023 | 1:46 pm

TMUS

Morgan Stanley analyst Simon Flannery has maintained an Overweight rating on T-Mobile US (NASDAQ:TMUS) and raised the price target from $178 to $179.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:46 pm

CORT

Truist Securities analyst Gregory Fraser has maintained a 'Hold' rating on Corcept Therapeutics (NASDAQ:CORT) and raised the price target from $26 to $29.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:46 pm

UTHR

Morgan Stanley analyst Terence Flynn maintains an Overweight rating on United Therapeutics (NASDAQ:UTHR) and raises the price target from $316 to $318.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:46 pm

ALTG

Zacks Home Run Investor Newsletter has picked Alta Equipment Group (ALTG) as a stock to watch.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 1:46 pm